EDGAR Filing Documents for 0001193125-17-204784

Form 8-K - Current report:

SEC Accession No. 0001193125-17-204784

Filing Date

2017-06-15

Accepted

2017-06-15 16:58:57

Documents

Period of Report

2017-06-14

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d413845d8k.htm	8-K	17851
2	EX-99.1	d413845dex991.htm	EX-99.1	7487
3	GRAPHIC	g413845g83k02.jpg	GRAPHIC	5475
	Complete submission text file	0001193125-17-204784.txt		34243

Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036

Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381

Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)